<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 10-QSB/A (AMENDMENT NO. 1)
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED June 30, 2000.
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM __________ TO ___________.
Commission file number 0-6523
MICRO THERAPEUTICS, INC.
(exact name of small business issuer as specified in its charter)
Delaware 33-0569235
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification Number)
2 Goodyear, Irvine, California 92618
(Address of principal executive offices)
(949) 837-3700
(Issuer's telephone number)
NOT APPLICABLE
(Former name, former address and former fiscal year,
if changed since last report)
Check whether the issuer (1) filed all reports to be filed by Section 13 or
15(d) of the Exchange Act during the past 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days.
Yes X No
--- ---
State the number of shares outstanding of each of the issuer's classes of common
equity as of the latest practicable date.
Class Outstanding at August 4, 2000
----- -----------------------------
Common Stock, $.001 par value 9,952,718
Transitional small business disclosure format: Yes No X
--- ---
EXPLANATORY NOTE
This amendment is to add Item 4, Submission of Matters to a Vote of Security
Holders, to the Registrant's quarterly report for the 26 weeks ended June 30,
2000.
Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended,
the text of the amendment is set forth in its entirety as attached hereto.
Page 1 of 4 Pages
<PAGE> 2
MICRO THERAPEUTICS, INC.
INDEX TO FORM 10-QSB/A
Page
Number
------
PART II. OTHER INFORMATION
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS..........3
SIGNATURES............................................................4
2
<PAGE> 3
PART II. OTHER INFORMATION
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
The annual meeting of stockholders was held on May 25, 2000. Of the 9,889,442
shares of the Company's common stock issued and outstanding and entitled to vote
at the meeting, there were present at the meeting, in person or by proxy, the
holders of 7,789,817 common shares, representing 79% of the total number of
shares entitled to vote at the meeting. This percentage represents a quorum. Two
proposals were presented and voted on at the stockholders' meeting.
Proposal One: Each of the five nominees to the Board of Directors was elected
for a one-year term by the stockholders. The directors elected were: George
Wallace, Dick Allen, Kim Blickenstaff, W. James Fitzsimmons and Wende Hutton.
The voting results were the same with respect to each of the individuals listed
above and were as follows: For, 7,750,353; Withheld, 39,464.
Proposal Two: The appointment of PricewaterhouseCoopers LLP as independent
auditors of the Company for the fiscal year ending December 31, 2000 was
ratified. The voting results were: For, 7,782,918; Against, 2,420; Abstain,
4,479.
3
<PAGE> 4
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
MICRO THERAPEUTICS, INC.
Date: November 3, 2000 By: /s/ Harold A. Hurwitz
-----------------------
Harold A. Hurwitz
Chief Financial Officer
4
